With a standard 10 mg/mL tirzepatide and 100 mg/mL levocarnitine formulation, each dose delivers levocarnitine proportionally
Monitor health: Keep up with your healthcare appointments to monitor for side effects and track progress
Patients should consume alcohol with or shortly after a meal containing carbohydrates, protein, and fat
The ATTAIN program for obesity includes ATTAIN-1 (NCT05869903, completed), ATTAIN-2 (NCT05872620, completed), ATTAIN-3 (completed), and ATTAIN-MAINTAIN (completed)
Individuals who received bupropion/naltrexone before GLP-1 analog therapy and those with surgical treatment for obesity before or during the study were excluded
Synergistic weight loss and diabetes resolution with exenatide administration after laparoscopic gastric banding